PT-141 – 10mg Melanocortin Agonist

Comprehensive Laboratory Profile

The acquisition of targeted central nervous system agonists provides institutional laboratories with the advanced capability to observe neuro-endocrine signaling and receptor-specific pathways in real-time. By integrating the PT-141 10mg peptide into institutional protocols, researchers gain access to a highly purified formulation engineered to simulate aggressive binding at the melanocortin receptors without inducing profound peripheral melanogenesis.

Synthesized within the USA to the most rigorous industry standards, this specialized complex delivers absolute analytical precision. Utilizing the PT-141 10mg formulation ensures your laboratory acquires reproducible data, free from the performance variability of degraded or improperly isolated hormone analogs.

Biochemical Profile: Central MC Receptor Agonist

The PT-141 formulation is a synthetically engineered, cyclic heptapeptide. It is a direct metabolite of Melanotan II, sharing the identical amino acid sequence but featuring a critical structural variation: a terminal hydroxyl group in place of a C-terminal amide.

This specific modification significantly alters its receptor binding profile. While it retains some affinity for the MC1R (the receptor responsible for pigmentation), the PT-141 10mg matrix exhibits a heavily biased affinity for the melanocortin 4 receptor (MC4R) and the melanocortin 3 receptor (MC3R) located within the central nervous system. This signaling profile is critical for studies focusing on neuro-vascular responses and the autonomic nervous system.

Mechanism of Action in Cellular Assays

When introduced to cellular monolayers or isolated neuronal tissue cultures, the PT-141 10mg compound functions as a synchronized kinetic trigger. Upon targeted binding to the MC4R on the cell surface, it initiates an intracellular cascade that rapidly elevates cyclic AMP (cAMP) levels within the neurons.

This downstream signaling bypasses the peripheral vascular system and operates directly via central nervous pathways to stimulate neuro-vascular downstream effects. By deploying this formulation, laboratories can document the aggressive stimulation of targeted neuronal receptors. This allows researchers to establish highly stable micro-environments where rapid synaptic signaling and neuro-endocrine responses can be monitored with total scientific clarity.

Primary In-Vitro Research Applications

The exceptional purity and targeted cyclic design of this neuropeptide make it a cornerstone for advanced neurological and endocrinological R&D:

• MC4R Affinity Modeling: Mapping the kinetic response and cAMP elevation in exposed neuronal cell models.

• Neuro-Vascular Assays: Evaluating the precise downstream activation rates of central nervous system signaling pathways.

• Receptor Selectivity Studies: Utilizing the PT-141 10mg complex to monitor binding bias between MC1R, MC3R, and MC4R under standardized conditions.

• Neuro-Endocrine Pathway R&D: Using this specific sequence to establish laboratory models for comparative efficacy testing against full-sequence alpha-MSH.

Absolute Purity and Quality Assurance

At Ion Peptides, we recognize that anomalous data caused by degraded or structurally compromised substrates critically jeopardizes institutional research funding. Every single batch of our PT-141 10mg peptide is subjected to uncompromising third-party analytical testing before being approved for acquisition.

We utilize High-Performance Liquid Chromatography (HPLC) to verify a purity threshold of >99.0%. Furthermore, rigorous Mass Spectrometry (MS) confirms the precise 7-amino acid sequence and the integrity of the crucial cyclic bridge. By securing your supply through our secure USA synthesis network and encrypted crypto gateways, you guarantee your facility receives elite, uncompromised materials.

Lyophilization, Storage, and Reconstitution Protocols

To ensure maximum molecular stability during secure domestic transit, the PT-141 10mg vial is supplied as a lyophilized (freeze-dried) solid powder.

• Storage: Keep vials in a climate-controlled, dark environment, ideally at or below -20°C. Protected from light and moisture, the unmixed powder remains stable for up to 36 months.

• Reconstitution: Utilize sterile bacteriostatic water.

  1. Allow the vial to reach ambient room temperature to prevent condensation.

  2. Introduce the diluent slowly, directing the fluid flow down the inner wall of the glass to prevent sheer stress on the peptide bonds.

  3. Do not agitate or vortex the vial. Allow the PT-141 10mg powder to dissolve naturally into a clear solution via gentle swirling.

  4. Once reconstituted, refrigerate immediately at 2°C to 8°C and utilize within standard laboratory protocol timelines.